CryoLife, Inc. (CryoLife) develops, manufactures and commercializes medical devices for cardiac and vascular applications and preserves and distributes human tissues for transplantation. The Company operates in two segments, including Medical Devices and Preservation Services. The Medical Devices segment includes revenues from product sales of BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), PerClot, revascularization technologies, HeRO Graft, and other products. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular tissues. The Company�s surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), and PerClot, a powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (SMI).